Another clinical trial was registered with an aim to determine if intravenous iron is non-inferior to blood transfusion in correcting Hb deficit and replenishing iron stores in women with acute post-partum anemia, though the result is not available yet (Chua et al., 2017). The gene discussed is GSTM1; the disease is anemia (phenotype).